JP2011522789A5 - - Google Patents

Download PDF

Info

Publication number
JP2011522789A5
JP2011522789A5 JP2011507540A JP2011507540A JP2011522789A5 JP 2011522789 A5 JP2011522789 A5 JP 2011522789A5 JP 2011507540 A JP2011507540 A JP 2011507540A JP 2011507540 A JP2011507540 A JP 2011507540A JP 2011522789 A5 JP2011522789 A5 JP 2011522789A5
Authority
JP
Japan
Prior art keywords
aryl
heteroaryl
alkyl
alkynyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011507540A
Other languages
English (en)
Japanese (ja)
Other versions
JP5502072B2 (ja
JP2011522789A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/041382 external-priority patent/WO2009134658A2/en
Publication of JP2011522789A publication Critical patent/JP2011522789A/ja
Publication of JP2011522789A5 publication Critical patent/JP2011522789A5/ja
Application granted granted Critical
Publication of JP5502072B2 publication Critical patent/JP5502072B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011507540A 2008-04-30 2009-04-22 オーロラキナーゼ阻害剤としての縮合二環式ピリミジン化合物 Active JP5502072B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4906308P 2008-04-30 2008-04-30
US61/049,063 2008-04-30
PCT/US2009/041382 WO2009134658A2 (en) 2008-04-30 2009-04-22 Fused bicyclic pyrimidine compounds as aurora kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2011522789A JP2011522789A (ja) 2011-08-04
JP2011522789A5 true JP2011522789A5 (enExample) 2012-06-14
JP5502072B2 JP5502072B2 (ja) 2014-05-28

Family

ID=41255689

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011507540A Active JP5502072B2 (ja) 2008-04-30 2009-04-22 オーロラキナーゼ阻害剤としての縮合二環式ピリミジン化合物

Country Status (12)

Country Link
US (1) US8138194B2 (enExample)
EP (1) EP2276346B1 (enExample)
JP (1) JP5502072B2 (enExample)
KR (1) KR101667822B1 (enExample)
CN (1) CN102014627B (enExample)
AU (1) AU2009241469B2 (enExample)
CA (1) CA2722220C (enExample)
DK (1) DK2276346T3 (enExample)
ES (1) ES2616255T3 (enExample)
PL (1) PL2276346T3 (enExample)
TW (1) TWI363627B (enExample)
WO (1) WO2009134658A2 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013515740A (ja) * 2009-12-23 2013-05-09 バイオクライスト ファーマシューティカルズ, インコーポレイテッド Janusキナーゼインヒビターとしての複素環式化合物
WO2011082273A2 (en) 2009-12-30 2011-07-07 Arqule, Inc. Substituted pyrrolo-aminopyrimidine compounds
TW201307347A (zh) 2010-11-01 2013-02-16 Arqule Inc 經取代苯並-咪唑並-吡啶並-二氮呯化合物
BR112014024251A8 (pt) * 2012-03-30 2018-01-23 Rhizen Pharmaceuticals S A novos compostos piridina 3,5-dissubstituída-3h-imidazo [4,5-b] e piridina 3,5-dissubstituída -3h-[1,2,3]triazolo[4,5-b] como moduladores de quinases de proteína c-met
JP6235001B2 (ja) 2012-05-21 2017-11-22 バイエル・ファルマ・アクティエンゲゼルシャフト 置換ベンゾチエノピリミジン
CA2873971A1 (en) 2012-05-21 2013-11-28 Bayer Pharma Aktiengesellschaft Substituted pyrrolopyrimidines
CN104507950B (zh) 2012-05-21 2017-03-22 拜耳医药股份有限公司 噻吩并嘧啶
MD20140130A2 (ro) 2012-06-29 2015-04-30 Pfizer Inc. 4-(amino-substituite)-7H-pirolo[2,3-d]pirimidine noi ca inhibitori de LRRK2
TW201412740A (zh) 2012-09-20 2014-04-01 Bayer Pharma AG 經取代之吡咯并嘧啶胺基苯并噻唑酮
CN103664993B (zh) * 2012-09-25 2016-05-25 韩冰 一类治疗缺血性脑损伤的化合物及其用途
CN103012428A (zh) * 2013-01-08 2013-04-03 中国药科大学 4-(五元杂环并嘧啶/吡啶取代)氨基-1H-3-吡唑甲酰胺类CDK/Aurora双重抑制剂及其用途
EP2951187A1 (en) 2013-02-01 2015-12-09 Bayer Pharma Aktiengesellschaft Substituted thienopyrimidines and pharmaceutical use thereof
US9675612B2 (en) 2013-03-06 2017-06-13 Bayer Pharma Aktiengesellschaft Substituted thiazolopyrimidines
WO2015092592A1 (en) 2013-12-17 2015-06-25 Pfizer Inc. Novel 3,4-disubstituted-1h-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7h-pyrrolo[2,3-c]pyridazines as lrrk2 inhibitors
MD20160112A2 (ro) 2014-04-25 2017-06-30 Pfizer Inc. Compuşi heteroaromatici şi utilizarea lor ca liganzi ai dopaminei D1
FR3037956B1 (fr) * 2015-06-23 2017-08-04 Servier Lab Nouveaux derives d'acide amine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN105061461B (zh) * 2015-08-18 2017-06-30 沈阳药科大学 含有苄胺结构的四氢苯并[4,5]噻吩并[2,3‑d]嘧啶类化合物及其应用
CN105061460B (zh) * 2015-08-18 2017-06-30 沈阳药科大学 含有硫醚结构的四氢苯并[4,5]噻吩并[2,3‑d]嘧啶类化合物及其应用
RU2722149C1 (ru) 2015-09-14 2020-05-27 Пфайзер Инк. Новые производные имидазо[4,5-c] хинолинов и имидазо[4,5-c][1,5] нафтиридинов в качестве ингибиторов LRRK2
US9630968B1 (en) 2015-12-23 2017-04-25 Arqule, Inc. Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof
FR3046792B1 (fr) * 2016-01-19 2018-02-02 Les Laboratoires Servier Nouveaux derives d'ammonium, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN106243124B (zh) * 2016-07-29 2018-03-09 湖北民族学院 一种噻吩并嘧啶脲类化合物及其制备方法和应用
BR112019003504A2 (pt) 2016-08-24 2019-05-21 Arqule, Inc. compostos de amino-pirrolopirimidinona e métodos de uso dos mesmos
CN106810512B (zh) * 2017-01-18 2019-09-10 江苏省中医药研究院 Idh2突变体抑制剂及其用途
TW201920193A (zh) * 2017-08-15 2019-06-01 美商艾伯維有限公司 大環mel-1抑制劑以及使用方法
CN111818917A (zh) * 2017-08-15 2020-10-23 艾伯维公司 大环mcl-1抑制剂和使用方法
US20200255451A1 (en) * 2017-08-15 2020-08-13 Abbvie Inc. Macrocyclic mcl-1 inhibitors and methods of use
PL4021452T3 (pl) * 2019-08-26 2024-05-06 Chemwerth Inc Podstawione związki (7h-pirolo[2,3-d]pirymidyn-4-ylo)aminowe przydatne jako inhibitory jak1
CN112500421B (zh) * 2020-12-15 2021-08-24 河南科技大学第一附属医院 一种可用于杀菌消毒的苯并吡喃脲类化合物的制备方法及应用
TW202413367A (zh) * 2022-08-19 2024-04-01 財團法人國家衛生研究院 Tam受體抑制劑
TW202508595A (zh) 2023-05-04 2025-03-01 美商銳新醫藥公司 用於ras相關疾病或病症之組合療法
WO2025034702A1 (en) 2023-08-07 2025-02-13 Revolution Medicines, Inc. Rmc-6291 for use in the treatment of ras protein-related disease or disorder
WO2025080946A2 (en) 2023-10-12 2025-04-17 Revolution Medicines, Inc. Ras inhibitors
WO2025171296A1 (en) 2024-02-09 2025-08-14 Revolution Medicines, Inc. Ras inhibitors
WO2025240847A1 (en) 2024-05-17 2025-11-20 Revolution Medicines, Inc. Ras inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4008726A1 (de) * 1990-03-19 1991-09-26 Basf Ag Thieno(2,3-d)pyrimidinderivate
HU230302B1 (hu) * 2000-10-20 2015-12-28 Eisai R&D Management Co., Ltd. Nitrogéntartalmú aromás származékok és ezeket tartalmazó gyógyászati készítmények
DE10141212A1 (de) 2001-08-22 2003-03-06 Bayer Ag Neue 4-Aminofuropyrimidine und ihre Verwendung
JP2005508904A (ja) 2001-09-11 2005-04-07 スミスクライン ビーチャム コーポレーション 血管新生阻害剤としてのフロ−及びチエノピリミジン誘導体
US6814324B2 (en) * 2002-07-03 2004-11-09 Segway Systems, Llc Releasably latchable leader block in tape threading apparatus for data storage systems and method therefor
BRPI0317717B8 (pt) 2002-12-24 2021-05-25 Astrazeneca Ab composto, composição farmacêutica, e uso de um composto
ATE437872T1 (de) * 2003-10-14 2009-08-15 Univ Arizona Proteinkinaseinhibitoren
US20050165029A1 (en) 2004-01-13 2005-07-28 Ambit Biosciences Corporation Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
KR20050091462A (ko) 2004-03-12 2005-09-15 한국과학기술연구원 푸로피리미딘 화합물 및 이를 포함하는 ddr2 티로신키나아제 활성 저해제
HRP20080120T5 (hr) 2004-05-14 2012-07-31 Millennium@Pharmaceuticals Spojevi i postupci za inhibiciju napredovanja mitoze s pomoću inhibicije aurora kinaze
WO2006004658A2 (en) 2004-06-29 2006-01-12 Amgen Inc. Furanopyrimidines
EP1781653A1 (en) 2004-07-05 2007-05-09 Astex Therapeutics Limited 3,4-disubstituted pyrazoles as cyclin dependent kinases (cdk) or aurora kinase or glycogen synthase 3 (gsk-3) inhibitors
CN101160316A (zh) * 2004-07-16 2008-04-09 苏内西斯医药公司 适合用作aurora激酶抑制剂的噻吩并嘧啶
ATE485300T1 (de) 2004-07-16 2010-11-15 Sunesis Pharmaceuticals Inc Als aurora-kinase-inhibitoren nutzbare thienopyrimidine
JP2009502801A (ja) 2005-07-22 2009-01-29 サネシス ファーマシューティカルズ, インコーポレイテッド Auroraキナーゼインヒビターとして有用なピラゾロピリミジン
DE102005037499A1 (de) * 2005-08-09 2007-02-15 Merck Patent Gmbh Pyrazolderivate
RU2008120850A (ru) * 2005-10-28 2009-12-10 Айрм Ллк (Bm) Соединения и композиции в качестве ингибиторов протеинкиназ
KR20080083680A (ko) 2005-12-23 2008-09-18 스미스클라인 비참 코포레이션 오로라 키나제의 아자인돌 억제제

Similar Documents

Publication Publication Date Title
JP2011522789A5 (enExample)
JP2013512915A5 (enExample)
JP2010511721A5 (enExample)
JP2012515776A5 (enExample)
JP2015534574A5 (enExample)
JP2013543845A5 (enExample)
JP2016505586A5 (enExample)
JP2016537368A5 (enExample)
JP2010504286A5 (enExample)
JP2009526868A5 (enExample)
JP2012505871A5 (enExample)
JP2012526842A5 (enExample)
JP2011513410A5 (enExample)
JP2014532060A5 (enExample)
RU2014117188A (ru) Способ получения производных 4,4-дифтор-3,4-дигидроизохинолина
JP2013544233A5 (enExample)
JP2013504593A5 (enExample)
JP2008525416A5 (enExample)
JP2016531121A5 (enExample)
CA2700598A1 (en) Nitrogen-containing heterocyclic compound and pest control agent
JP2008510828A5 (enExample)
JP2007523139A5 (enExample)
JP2013536188A5 (enExample)
WO2008108380A3 (en) Pyrrole compounds
JP2010527913A5 (enExample)